Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.

Goswami ND, Tsalik EL, Naggie S, Miller WC, Horton JR, Pfeiffer CD, Hicks CB.

Trials. 2014 Jan 22;15:31. doi: 10.1186/1745-6215-15-31.

2.

Spine device clinical trials: design and sponsorship.

Cher DJ, Capobianco RA.

Spine J. 2015 May 1;15(5):1133-40. doi: 10.1016/j.spinee.2015.01.027. Epub 2015 Jan 28.

PMID:
25637470
3.

Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.

Montedori A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I.

Trials. 2011 Feb 28;12:58. doi: 10.1186/1745-6215-12-58.

4.

Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.

Roumiantseva D, Carini S, Sim I, Wagner TH.

Contemp Clin Trials. 2013 Mar;34(2):348-55. doi: 10.1016/j.cct.2013.01.004. Epub 2013 Feb 1.

PMID:
23380028
5.

Industry sponsorship and positive outcome in vascular and endovascular randomised trials.

Hajibandeh S, Hajibandeh S, Antoniou SA, Antoniou GA, Torella F.

Vasa. 2017 Jan;46(1):67-68. doi: 10.1024/0301-1526/a000592. Epub 2016 Nov 28. No abstract available.

PMID:
27889961
6.

Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.

Flacco ME, Manzoli L, Boccia S, Capasso L, Aleksovska K, Rosso A, Scaioli G, De Vito C, Siliquini R, Villari P, Ioannidis JP.

J Clin Epidemiol. 2015 Jul;68(7):811-20. doi: 10.1016/j.jclinepi.2014.12.016. Epub 2015 Feb 7. Review.

7.

Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Rasmussen N, Lee K, Bero L.

Trials. 2009 Dec 16;10:116. doi: 10.1186/1745-6215-10-116.

8.

Industry sponsorship and selection of comparators in randomized clinical trials.

Lathyris DN, Patsopoulos NA, Salanti G, Ioannidis JP.

Eur J Clin Invest. 2010 Feb;40(2):172-82. doi: 10.1111/j.1365-2362.2009.02240.x. Epub 2009 Dec 27. Review.

PMID:
20050879
9.

Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A.

JAMA. 2012 May 2;307(17):1838-47. doi: 10.1001/jama.2012.3424.

PMID:
22550198
10.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

11.

Relationship between sponsorship and failure rate of dental implants: a systematic approach.

Popelut A, Valet F, Fromentin O, Thomas A, Bouchard P.

PLoS One. 2010 Apr 21;5(4):e10274. doi: 10.1371/journal.pone.0010274.

12.

The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.

Barton S, Peckitt C, Sclafani F, Cunningham D, Chau I.

Eur J Cancer. 2015 Dec;51(18):2732-9. doi: 10.1016/j.ejca.2015.08.030. Epub 2015 Nov 19. Review.

PMID:
26608121
13.

Effect of Industry Sponsorship on Dental Restorative Trials.

Schwendicke F, Tu YK, Blunck U, Paris S, Göstemeyer G.

J Dent Res. 2016 Jan;95(1):9-16. doi: 10.1177/0022034515609270. Epub 2015 Oct 6. Review.

PMID:
26442947
14.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

15.

Investigator experiences with financial conflicts of interest in clinical trials.

Rochon PA, Sekeres M, Hoey J, Lexchin J, Ferris LE, Moher D, Wu W, Kalkar SR, Van Laethem M, Gruneir A, Gold J, Maskalyk J, Streiner DL, Taback N, Chan AW.

Trials. 2011 Jan 12;12:9. doi: 10.1186/1745-6215-12-9.

16.

Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.

Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM.

PLoS Med. 2009 Sep;6(9):e1000144. doi: 10.1371/journal.pmed.1000144. Epub 2009 Sep 8.

17.

Evaluating solutions to sponsorship bias.

Doucet M, Sismondo S.

J Med Ethics. 2008 Aug;34(8):627-30. doi: 10.1136/jme.2007.022467.

PMID:
18667655
18.

Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.

Nkansah N, Nguyen T, Iraninezhad H, Bero L.

Public Health Nutr. 2009 Oct;12(10):1931-7. doi: 10.1017/S136898000900487X. Epub 2009 Mar 2.

PMID:
19254426
19.

Sponsors' participation in conduct and reporting of industry trials: a descriptive study.

Lundh A, Krogsbøll LT, Gøtzsche PC.

Trials. 2012 Aug 24;13:146. doi: 10.1186/1745-6215-13-146.

20.

Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.

Alturki R, Schandelmaier S, Olu KK, von Niederhäusern B, Agarwal A, Frei R, Bhatnagar N, Hooft L, von Elm E, Briel M.

J Clin Epidemiol. 2017 Jan;81:56-63. doi: 10.1016/j.jclinepi.2016.08.011. Epub 2016 Sep 8.

PMID:
27614277

Supplemental Content

Support Center